
The global market for Wearable Continuous Glucose Monitor (CGM) was valued at US$ 5959 million in the year 2024 and is projected to reach a revised size of US$ 23010 million by 2031, growing at a CAGR of 21.6% during the forecast period.
A continuous glucose monitor (CGM) is a wearable device that tracks blood glucose (sugar) every few minutes, throughout the day and night. The readings are relayed in real time to a device which can be read by the patient, caregiver or health-care provider, even remotely.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Wearable Continuous Glucose Monitor (CGM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Continuous Glucose Monitor (CGM).
The Wearable Continuous Glucose Monitor (CGM) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wearable Continuous Glucose Monitor (CGM) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Wearable Continuous Glucose Monitor (CGM) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Segment by Type
Type 1 Diabetes
Type 2 Diabetes
Segment by Application
Child
Adult
Elderly
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Continuous Glucose Monitor (CGM) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Continuous Glucose Monitor (CGM) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Wearable Continuous Glucose Monitor (CGM) Market Overview
1.1 Product Definition
1.2 Wearable Continuous Glucose Monitor (CGM) by Type
1.2.1 Global Wearable Continuous Glucose Monitor (CGM) Market Value Comparison by Type (2024 VS 2031)
1.2.2 Type 1 Diabetes
1.2.3 Type 2 Diabetes
1.3 Wearable Continuous Glucose Monitor (CGM) by Application
1.3.1 Global Wearable Continuous Glucose Monitor (CGM) Market Value by Application (2024 VS 2031)
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Global Wearable Continuous Glucose Monitor (CGM) Market Size Estimates and Forecasts
1.4.1 Global Wearable Continuous Glucose Monitor (CGM) Revenue 2020-2031
1.4.2 Global Wearable Continuous Glucose Monitor (CGM) Sales 2020-2031
1.4.3 Global Wearable Continuous Glucose Monitor (CGM) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Wearable Continuous Glucose Monitor (CGM) Market Competition by Manufacturers
2.1 Global Wearable Continuous Glucose Monitor (CGM) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Wearable Continuous Glucose Monitor (CGM) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Wearable Continuous Glucose Monitor (CGM), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Wearable Continuous Glucose Monitor (CGM), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Wearable Continuous Glucose Monitor (CGM), Product Type & Application
2.7 Global Key Manufacturers of Wearable Continuous Glucose Monitor (CGM), Date of Enter into This Industry
2.8 Global Wearable Continuous Glucose Monitor (CGM) Market Competitive Situation and Trends
2.8.1 Global Wearable Continuous Glucose Monitor (CGM) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Wearable Continuous Glucose Monitor (CGM) Players Market Share by Revenue
2.8.3 Global Wearable Continuous Glucose Monitor (CGM) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Wearable Continuous Glucose Monitor (CGM) Market Scenario by Region
3.1 Global Wearable Continuous Glucose Monitor (CGM) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Wearable Continuous Glucose Monitor (CGM) Sales by Region: 2020-2031
3.2.1 Global Wearable Continuous Glucose Monitor (CGM) Sales by Region: 2020-2025
3.2.2 Global Wearable Continuous Glucose Monitor (CGM) Sales by Region: 2026-2031
3.3 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Region: 2020-2031
3.3.1 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Region: 2020-2025
3.3.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Region: 2026-2031
3.4 North America Wearable Continuous Glucose Monitor (CGM) Market Facts & Figures by Country
3.4.1 North America Wearable Continuous Glucose Monitor (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Wearable Continuous Glucose Monitor (CGM) Sales by Country (2020-2031)
3.4.3 North America Wearable Continuous Glucose Monitor (CGM) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Wearable Continuous Glucose Monitor (CGM) Market Facts & Figures by Country
3.5.1 Europe Wearable Continuous Glucose Monitor (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Wearable Continuous Glucose Monitor (CGM) Sales by Country (2020-2031)
3.5.3 Europe Wearable Continuous Glucose Monitor (CGM) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Wearable Continuous Glucose Monitor (CGM) Market Facts & Figures by Region
3.6.1 Asia Pacific Wearable Continuous Glucose Monitor (CGM) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Wearable Continuous Glucose Monitor (CGM) Sales by Region (2020-2031)
3.6.3 Asia Pacific Wearable Continuous Glucose Monitor (CGM) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Wearable Continuous Glucose Monitor (CGM) Market Facts & Figures by Country
3.7.1 Latin America Wearable Continuous Glucose Monitor (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Wearable Continuous Glucose Monitor (CGM) Sales by Country (2020-2031)
3.7.3 Latin America Wearable Continuous Glucose Monitor (CGM) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Wearable Continuous Glucose Monitor (CGM) Market Facts & Figures by Country
3.8.1 Middle East and Africa Wearable Continuous Glucose Monitor (CGM) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Wearable Continuous Glucose Monitor (CGM) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Wearable Continuous Glucose Monitor (CGM) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Wearable Continuous Glucose Monitor (CGM) Sales by Type (2020-2031)
4.1.1 Global Wearable Continuous Glucose Monitor (CGM) Sales by Type (2020-2025)
4.1.2 Global Wearable Continuous Glucose Monitor (CGM) Sales by Type (2026-2031)
4.1.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Market Share by Type (2020-2031)
4.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Type (2020-2031)
4.2.1 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Type (2020-2025)
4.2.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Type (2026-2031)
4.2.3 Global Wearable Continuous Glucose Monitor (CGM) Revenue Market Share by Type (2020-2031)
4.3 Global Wearable Continuous Glucose Monitor (CGM) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Wearable Continuous Glucose Monitor (CGM) Sales by Application (2020-2031)
5.1.1 Global Wearable Continuous Glucose Monitor (CGM) Sales by Application (2020-2025)
5.1.2 Global Wearable Continuous Glucose Monitor (CGM) Sales by Application (2026-2031)
5.1.3 Global Wearable Continuous Glucose Monitor (CGM) Sales Market Share by Application (2020-2031)
5.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Application (2020-2031)
5.2.1 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Application (2020-2025)
5.2.2 Global Wearable Continuous Glucose Monitor (CGM) Revenue by Application (2026-2031)
5.2.3 Global Wearable Continuous Glucose Monitor (CGM) Revenue Market Share by Application (2020-2031)
5.3 Global Wearable Continuous Glucose Monitor (CGM) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dexcom
6.1.1 Dexcom Company Information
6.1.2 Dexcom Description and Business Overview
6.1.3 Dexcom Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dexcom Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.1.5 Dexcom Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Company Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Laboratories Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Medtronic Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Senseonics Holdings
6.4.1 Senseonics Holdings Company Information
6.4.2 Senseonics Holdings Description and Business Overview
6.4.3 Senseonics Holdings Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Senseonics Holdings Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.4.5 Senseonics Holdings Recent Developments/Updates
6.5 GlySens Incorporated
6.5.1 GlySens Incorporated Company Information
6.5.2 GlySens Incorporated Description and Business Overview
6.5.3 GlySens Incorporated Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlySens Incorporated Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.5.5 GlySens Incorporated Recent Developments/Updates
6.6 Meiqi Medical Equipment
6.6.1 Meiqi Medical Equipment Company Information
6.6.2 Meiqi Medical Equipment Description and Business Overview
6.6.3 Meiqi Medical Equipment Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Meiqi Medical Equipment Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.6.5 Meiqi Medical Equipment Recent Developments/Updates
6.7 San Meditech
6.7.1 San Meditech Company Information
6.7.2 San Meditech Description and Business Overview
6.7.3 San Meditech Wearable Continuous Glucose Monitor (CGM) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 San Meditech Wearable Continuous Glucose Monitor (CGM) Product Portfolio
6.7.5 San Meditech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Wearable Continuous Glucose Monitor (CGM) Industry Chain Analysis
7.2 Wearable Continuous Glucose Monitor (CGM) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Wearable Continuous Glucose Monitor (CGM) Production Mode & Process Analysis
7.4 Wearable Continuous Glucose Monitor (CGM) Sales and Marketing
7.4.1 Wearable Continuous Glucose Monitor (CGM) Sales Channels
7.4.2 Wearable Continuous Glucose Monitor (CGM) Distributors
7.5 Wearable Continuous Glucose Monitor (CGM) Customer Analysis
8 Wearable Continuous Glucose Monitor (CGM) Market Dynamics
8.1 Wearable Continuous Glucose Monitor (CGM) Industry Trends
8.2 Wearable Continuous Glucose Monitor (CGM) Market Drivers
8.3 Wearable Continuous Glucose Monitor (CGM) Market Challenges
8.4 Wearable Continuous Glucose Monitor (CGM) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
Ìý
Ìý
*If Applicable.
